Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study designed to evaluate the safety and efficacy of double staining with brilliant blue G
0.025% as an adjuvant to macular surgery. Patients undergoing surgery for macular hole or
epiretinal membrane will be included. Safety will be evaluated by optic coherence tomography,
pattern reversal electroretinogram and multifocal electroretinogram.